Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · IEX Real-Time Price · USD
24.91 0.58 (2.38%)
Oct 26, 2021 10:59 AM EDT - Market open
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 |
|---|---|---|
| Selling, General & Admin | 4.68 | 1.01 |
| Research & Development | 9.1 | 13.9 |
| Other Operating Expenses | 0.03 | 0 |
| Operating Expenses | 13.81 | 14.91 |
| Operating Income | -13.81 | -14.91 |
| Interest Expense / Income | 0.03 | 2.08 |
| Other Expense / Income | 30 | 0 |
| Pretax Income | -43.84 | -16.98 |
| Net Income | -43.84 | -16.98 |
| Net Income Common | -43.84 | -16.98 |
| Shares Outstanding (Basic) | 6 | 6 |
| Shares Outstanding (Diluted) | 6 | 6 |
| Shares Change | -6.67% | - |
| EPS (Basic) | -7.33 | -2.13 |
| EPS (Diluted) | -7.33 | -2.13 |
| Free Cash Flow Per Share | -0.00 | -0.00 |
| EBITDA | -43.81 | -14.91 |
| EBIT | -43.81 | -14.91 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).